DocDollars

Neotract Inc.

CA · United States · Reporting entity ID 100000071387

Total reported 2019–2025
$6.52M
#622 of 2,960 reporting companies — 0% of all reported industry payments
$6.10M in general payments across 20,922 records, plus $419K in research funding across 49 records.

How it breaks down

General payments $6,104,677
Research funding $418,823

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Neotract Inc. reported $6.52M to US doctors and teaching hospitals from 2019 to 2025, ranking #622 of 2,960 reporting companies. 6% of that was research funding and 94% general payments such as consulting, speaking, food and travel. 20,922 general payment records and 49 research records were filed.

Common questions about Neotract Inc.

How much has Neotract Inc. paid US doctors?

Neotract Inc. reported $6,523,500 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,104,677 in general payments, $418,823 in research funding.

How does Neotract Inc. rank among drug and device companies?

It ranks #622 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Neotract Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.